Related Experiment Video
Updated: Aug 20, 2025
06:41
A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis
Published on: March 9, 2015
9.0K
Oral Minoxidil for Chemotherapy-Induced Alopecia
Fabrizio Martora1, Marina Vastarella1, Davide Fattore1
1Section of Dermatology, Department of Clinical Medicine and Surgery, University Hospital Federico II, Naples, Italy.
Skin Appendage Disorders
|November 21, 2022
Summary
Chemotherapy-induced alopecia (CIA) affects many patients undergoing cancer treatment. A 64-year-old patient experienced good results when treated with oral minoxidil for CIA.
Area of Science:
- Oncology
- Dermatology
Background:
- Chemotherapy-induced alopecia (CIA) is a common and distressing side effect of cytotoxic chemotherapy, impacting approximately 65% of patients.
- Managing CIA presents a significant challenge in supportive cancer care.
Observation:
- This report details the case of a 64-year-old patient experiencing chemotherapy-induced alopecia.
Findings:
- The patient was treated with oral minoxidil, which demonstrated positive outcomes in hair regrowth.
- This case highlights the potential efficacy of oral minoxidil in managing CIA.
Implications:
- This case contributes valuable clinical data for exploring novel therapeutic strategies for chemotherapy-induced alopecia.
- Further research into oral minoxidil as a treatment for CIA is warranted to establish its broader applicability and effectiveness.
Related Concept Videos
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
293
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
293
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
411
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
411
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
245
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
245
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
359
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
359
01:23Antihypertensive Drugs: Vasodilators
611
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
611